A fresh Trump tariff warning dragged pharma stocks lower on Tuesday. Investors turned cautious after Donald Trump proposed steep duties on imported generic drugs.
The US Cancer Market has moved a step closer for Alembic Pharma and Natco Pharma after the companies secured a key regulatory milestone.
The suspension of Premarin vaginal cream by Pfizer has drawn attention for its immediate impact, and also signals in evolving priorities in the Indian market
The India-UK FTA has sparked a fresh debate across India's pharmaceutical sector. Drugmakers see the agreement as a major export opportunity.
Generic Semaglutide has helped Sun Pharmaceutical Industries expand its global presence with a fresh regulatory win.
The Indian Pharma Industry is moving towards a biosimilars manufacturing growth phase. Earlier this year, India was the subject of a global collaboration that reflects growing international trust in its abilities
Mankind Pharma has approved two major strategic decisions to sharpen its long-term growth strategy. The company will sell its hospitality business for Rs49 crore.
Reproductive rights have come sharply into focus in India as the National Commission for Women (NCW) initiates a comprehensive review of the regulatory framework
Wegovy is making a strong comeback in India's fast-growing weight loss drug market as generic weight loss drugs begin to lose momentum.
The weight loss pills race is entering a new phase as smaller biotech companies move closer to challenging Big Pharma in the fast-growing obesity drug market.
.jpg)
, CDSCO.jpg)